Stay updated on LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Sign up to get notified when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.

Latest updates to the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check35 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check63 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check78 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed background information on malignant pleural mesotheliomas and the study drug LMB-100, while adding a new version revision and a location for the study.SummaryDifference47%
Stay in the know with updates to LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.